Phase 1b Dose-finding Study of Venetoclax With Ibrutinib and Rituximab in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma

oleh: Alessandra Petrillo, Andrew Ip, Alexandra Della Pia, Sarvainder Gill, Joshua Zenreich, Martin Gutierrez, Ann McNeill, Tatyana Feldman, Lori A. Leslie, Andre Goy

Format: Article
Diterbitkan: Wiley 2022-06-01

Deskripsi

No description available for this item.